The CFU Assay: In Vitro Functional Potency Assessment for Hematopoietic Stem and Progenitor Cells

The colony-forming unit (CFU) assay remains the only in vitro assay that provides a correlative assessment of hematopoietic stem and progenitor cell (HSPC) engraftment potential in vivo. For many years, regulatory bodies have recommended functional assessment and the CFU assay for labs working with cellular therapies or transplantable products derived from HSPCs. Recent updates from regulatory bodies such as FACT underscore the crucial role of the CFU assay in these workflows, particularly after any processing step, such as cryopreservation, that may impact the functional properties of HSPC products.

In this webinar, Selena Hallahan introduces the utility of the CFU assay for functional assessment of hematopoietic cell products and ��ƽ�� Technologies’ comprehensive portfolio of reagents, training, and services designed to support high-performing and standardized workflows for hematopoietic cell therapy products.

This webinar introduces the utility of the CFU assay for the functional assessment of hematopoietic cell products and how recent regulatory updates emphasize its importance in cellular therapies. You will also learn about ��ƽ�� Technologies’ comprehensive portfolio of reagents, training, and services designed to support high-performing and standardized workflows for hematopoietic cell therapy products.

Publish Date: October 04, 2024

Request Webinar Form

See other videos & webinars

Webinar: The CFU Assay: In Vitro Functional Potency Assessment for Hematopoietic Stem and Progenitor Cells

The colony-forming unit (CFU) assay remains the only in vitro assay that provides a correlative assessment of hematopoietic stem and progenitor cell (HSPC) engraftment potential in vivo. For many years, regulatory bodies have recommended functional assessment and the CFU assay for labs working with cellular therapies or transplantable products derived from HSPCs. Recent updates from regulatory bodies such as FACT underscore the crucial role of the CFU assay in these workflows, particularly after any processing step, such as cryopreservation, that may impact the functional properties of HSPC products.

In this webinar, Selena Hallahan introduces the utility of the CFU assay for functional assessment of hematopoietic cell products and ��ƽ�� Technologies’ comprehensive portfolio of reagents, training, and services designed to support high-performing and standardized workflows for hematopoietic cell therapy products.

To view the webinar, please complete the form, or sign in to your account.

I agree to receive future electronic communications from ��ƽ��. I acknowledge that I can unsubscribe at any time.

By submitting this form, you are providing your consent to ��ƽ�� Technologies Canada Inc. and its subsidiaries and affiliates (“��ƽ��”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.

Request Pricing

Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):

Estimated delivery time for your area

Product sample or exclusive offer

In-lab demonstration

Explore Our Products

EasySep™ Human CD34 Positive Selection Kit II

Immunomagnetic positive selection of human CD34+ cells
��շ��ѱ��ǲ�™

Automated and standardized colony counting for the hematopoietic colony-forming unit (CFU) assay
��ٱ𳾳��貹��™-��

cGMP medium, for culture and expansion of human hematopoietic cells
MethoCult™ H4034 Optimum

Methylcellulose-based medium with recombinant cytokines for human cells

�����ƽ��